Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00342212 · ClinicalTrials.gov registry record

Actigraph Accelerometer Validation Study

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status

NCT00342212: Completed study, sponsored by National Cancer Institute (NCI).

NCT00342212 is a clinical trial that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00342212 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status

Study Summary

Background: * Good measures of physical activity are needed for studies correlating physical activity and the risk of developing certain diseases. * In preparation for use in a study of diseases and risk factors in Hispanic populations, NCI is evaluating a new model accelerometer to measure physical activity. An accelerometer is a small device worn on a belt at the waist that measures and records movement, capturing movement intensity and duration and associating it with clock-time. * The new accelerometer (ActiGraph GTIM) uses a different type of motion detector from that used in the previous model (ActiGraph 7164). Objective: To evaluate and compare the ActiGraph GTIM with the ActiGraph 7164 by collecting physical activity data using both models. Eligibility: Men and women 18-74 years of age. Design: Study participants wear both model accelerometers while they walk or jog around a track at several self-selected paces. Data from the two devices are compared.

Trial Details

FieldValue
Start Date 2006-03
Est. Completion 2008-04

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT00342212

The ClinicalTrials.gov registry entry for NCT00342212 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00342212 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00342212 about?

NCT00342212 is a clinical study titled "Actigraph Accelerometer Validation Study". Background: * Good measures of physical activity are needed for studies correlating physical activity and the risk of developing certain diseases. * In preparation for use in a study of diseases and risk factors in Hispanic populations, NCI is evaluating a new model accelerometer to measure physica...

What is the current status of trial NCT00342212?

This trial is currently completed. The study started on 2006-03. Estimated completion is 2008-04.

Who is sponsoring clinical trial NCT00342212?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.